Jones Financial Companies
HAE icon

Jones Financial Companies’s Haemonetics HAE Stock Holding History

Jones Financial Companies’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.8K Sell
579
-53
-8% -$3.4K ﹤0.01% 3180
2026
Q1 		$34.2K Sell
632
-109
-15% -$7.1K ﹤0.01% 3088
2025
Q4 		$59.4K Buy
741
+456
+160% +$30.6K ﹤0.01% 2439
2025
Q3 		$13.7K Buy
285
+35
+14% +$2.17K ﹤0.01% 2961
2025
Q2 		$18.4K Buy
250
+101
+68% +$6.69K ﹤0.01% 2631
2025
Q1 		$9.41K Hold
149
– – ﹤0.01% 2741
2024
Q4 		$11.6K Hold
149
– – ﹤0.01% 2466
2024
Q3 		$11.9K Buy
+149
New +$12K ﹤0.01% 2159
2021
Q1 		– Sell
-13
Closed -$2K – 808
2020
Q4 		$2K Buy
+13
New +$1.4K ﹤0.01% 600

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's HAE Position: Q2 2026 in Review

Jones Financial Companies reduced its Haemonetics (HAE) stake by 8.4% in Q2 2026, selling an estimated $3.4K and leaving 579 shares worth $44.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3180.

Jones Financial Companies first reported a position in HAE in Q4 2020 and has held it in 9 quarters since. The position peaked at $59.4K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Jones Financial Companies held 579 shares of Haemonetics worth $44.8K as of Q2 2026.
  • Jones Financial Companies sold 53 Haemonetics shares in Q2 2026, an estimated $3.4K.
  • Haemonetics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3180 holding.
  • Jones Financial Companies first reported a position in Haemonetics in Q4 2020 and has held it in 9 quarters since.
  • Jones Financial Companies's Haemonetics position peaked at $59.4K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.